GlycoMimetics Inc. (GLYC)
NASDAQ: GLYC
· Real-Time Price · USD
17.09
-0.91 (-5.06%)
At close: Jun 26, 2025, 3:24 PM
16.84
-1.46%
After-hours: Jun 26, 2025, 04:01 PM EDT
-5.06% (1D)
| Bid | n/a |
| Market Cap | 1.1B |
| Revenue (ttm) | 54.09K |
| Net Income (ttm) | -29.49M |
| EPS (ttm) | -46 |
| PE Ratio (ttm) | -0.37 |
| Forward PE | -5.86 |
| Analyst | n/a |
| Ask | n/a |
| Volume | 42,768 |
| Avg. Volume (20D) | 19,728 |
| Open | 15.51 |
| Previous Close | 18.00 |
| Day's Range | 15.51 - 18.89 |
| 52-Week Range | 0.15 - 63.00 |
| Beta | 1.60 |
About GLYC
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol GLYC
Website n/a
3 weeks ago
-5.43%
GlycoMimetics shares are trading higher after the ...
Unlock content with
Pro Subscription
8 months ago
+191.32%
GlycoMimetics shares are trading higher after the company announced it will merge with Crescent Biopharma and secured $200 in funding to advance its oncology pipeline.
